Meditor Pharmaceuticals Ltd. Report issue

For profit Phase 2
Founded: Ness Ziona Israel (1998)
Status: Acquired by American Medical Technologies, Inc. (2009)

Organization Overview

First Clinical Trial
2006
NCT00448071
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (2)

ethylisothiouronium (1 trial)

mtr105 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypotension (Phase 2)

Kidney Diseases (Phase 2)

Kidney Failure, Chronic (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2